These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23635829)

  • 1. Synthesis and biological evaluation of 68Ga labeled bis-DOTA-3,3'-(benzylidene)-bis-(1H-indole-2-carbohydrazide) as a PET tracer for in vivo visualization of necrosis.
    Prinsen K; Cona MM; Cleynhens J; Vanbilloen H; Li J; Dyubankova N; Lescrinier E; Bormans G; Ni Y; Verbruggen A
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3216-20. PubMed ID: 23635829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and evaluation of a 68Ga labeled pamoic acid derivative for in vivo visualization of necrosis using positron emission tomography.
    Prinsen K; Li J; Vanbilloen H; Vermaelen P; Devos E; Mortelmans L; Bormans G; Ni Y; Verbruggen A
    Bioorg Med Chem; 2010 Jul; 18(14):5274-81. PubMed ID: 20580560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of 68Ga-bis-DOTA-PA as a potential agent for positron emission tomography imaging of necrosis.
    Prinsen K; Cona MM; Cleynhens BJ; Li J; Vanbilloen H; Dyubankova N; Lescrinier E; Ni Y; Bormans GM; Verbruggen AM
    Nucl Med Biol; 2013 Aug; 40(6):816-22. PubMed ID: 23915800
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeling and preliminary biological evaluation of a (99m)Tc(CO)(3) labeled 3,3'-(benzylidene)-bis-(1H-indole-2-carbohydrazide) derivative as a potential SPECT tracer for in vivo visualization of necrosis.
    Prinsen K; Jin L; Vunckx K; De Saint-Hubert M; Zhou L; Cleynhens J; Nuyts J; Bormans G; Ni Y; Verbruggen A
    Bioorg Med Chem Lett; 2011 Jan; 21(1):502-5. PubMed ID: 21075631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and Evaluation of Ga-68-Labeled Rhein for Early Assessment of Treatment-Induced Tumor Necrosis.
    Zhang A; Wu T; Bian L; Li P; Liu Q; Zhang D; Jin Q; Zhang J; Huang G; Song S
    Mol Imaging Biol; 2020 Jun; 22(3):515-525. PubMed ID: 31250330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and evaluation of a novel 68Ga-labeled DOTA-benzamide derivative for malignant melanoma imaging.
    Kim HJ; Kim DY; Park JH; Yang SD; Hur MG; Min JJ; Yu KH
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5288-92. PubMed ID: 22796183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative Evaluation of Using NOTA and DOTA Derivatives as Bifunctional Chelating Agents in the Preparation of
    Guleria M; Das T; Amirdhanayagam J; Sarma HD; Dash A
    Cancer Biother Radiopharm; 2018 Feb; 33(1):8-16. PubMed ID: 29373046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography.
    Pathuri G; Hedrick AF; January SE; Galbraith WK; Awasthi V; Arnold CD; Cowley BD; Gali H
    J Labelled Comp Radiopharm; 2015 Jan; 58(1):14-9. PubMed ID: 25545452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of 68Ga-labeled DOTA-nitroimidazole derivatives and their feasibilities as hypoxia imaging PET tracers.
    Hoigebazar L; Jeong JM; Hong MK; Kim YJ; Lee JY; Shetty D; Lee YS; Lee DS; Chung JK; Lee MC
    Bioorg Med Chem; 2011 Apr; 19(7):2176-81. PubMed ID: 21419635
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Ga-DOTA-based bifunctional radiopharmaceuticals: two functional moieties can be conjugated to radiogallium-DOTA without reducing the complex stability.
    Mukai T; Suwada J; Sano K; Okada M; Yamamoto F; Maeda M
    Bioorg Med Chem; 2009 Jul; 17(13):4285-9. PubMed ID: 19481944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Jain A; Mathur A; Pandey U; Sarma HD; Dash A
    Bioorg Med Chem Lett; 2016 Dec; 26(23):5785-5791. PubMed ID: 27793567
    [TBL] [Abstract][Full Text] [Related]  

  • 13. H(2)azapa: a versatile acyclic multifunctional chelator for (67)Ga, (64)Cu, (111)In, and (177)Lu.
    Bailey GA; Price EW; Zeglis BM; Ferreira CL; Boros E; Lacasse MJ; Patrick BO; Lewis JS; Adam MJ; Orvig C
    Inorg Chem; 2012 Nov; 51(22):12575-89. PubMed ID: 23106422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel DOTA-neurotensin analogues for 111In scintigraphy and 68Ga PET imaging of neurotensin receptor-positive tumors.
    Alshoukr F; Prignon A; Brans L; Jallane A; Mendes S; Talbot JN; Tourwé D; Barbet J; Gruaz-Guyon A
    Bioconjug Chem; 2011 Jul; 22(7):1374-85. PubMed ID: 21662976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel "bi-modal" H
    Ramogida CF; Murphy L; Cawthray JF; Ross JD; Adam MJ; Orvig C
    J Inorg Biochem; 2016 Sep; 162():253-262. PubMed ID: 26652124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro and in vivo characterization of three 68Ga- and 111In-labeled peptides for cholecystokinin receptor imaging.
    Roosenburg S; Laverman P; Joosten L; Eek A; Rutjes FP; van Delft FL; Boerman OC
    Mol Imaging; 2012; 11(5):401-7. PubMed ID: 22954184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and preclinical evaluation of (66)Ga-DOTA-E(c(RGDfK))2 as a potential theranostic radiopharmaceutical.
    Lopez-Rodriguez V; Gaspar-Carcamo RE; Pedraza-Lopez M; Rojas-Calderon EL; Arteaga de Murphy C; Ferro-Flores G; Avila-Rodriguez MA
    Nucl Med Biol; 2015 Feb; 42(2):109-14. PubMed ID: 25316595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and evaluation of
    Chakraborty S; Goswami D; Chakravarty R; Mohammed SK; Sarma HD; Dash A
    Chem Biol Drug Des; 2018 Sep; 92(3):1618-1626. PubMed ID: 29729071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent.
    Jammaz IA; Al-Otaibi B; Al-Hokbani N; Okarvi SM
    Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.